This session delves into the cognitive challenges often faced by individuals with myotonic dystrophy type 2 (DM2), focusing on issues such as memory loss and executive function difficulties. Learn about the latest research on DM2’s cognitive impact and practical techniques to help manage these symptoms in daily life.
Presenter:
- Araya Puwanant, MD, Wake Forest University School of Medicine
Thank you to our 2025 MDF Conference Sponsors for helping make this event possible:
- Lead Sponsor: Avidity Biosciences
- Diamond Sponsors: Dyne Therapeutics and Arthex Biotech
- Platinum Sponsors: PepGen and Vertex Pharmaceuticals
- Gold Sponsor: Sanofi
- Bronze Sponsor: Lupin Neurosciences